Literature DB >> 17428290

Repeat organ transplantation in the United States, 1996-2005.

J C Magee1, M L Barr, G P Basadonna, M R Johnson, S Mahadevan, M A McBride, D E Schaubel, A B Leichtman.   

Abstract

The prospect of graft loss is a problem faced by all transplant recipients, and retransplantation is often an option when loss occurs. To assess current trends in retransplantation, we analyzed data for retransplant candidates and recipients over the last 10 years, as well as current outcomes. During 2005, retransplant candidates represented 13.5%, 7.9%, 4.1% and 5.5% of all newly registered kidney, liver, heart and lung candidates, respectively. At the end of 2005, candidates for retransplantation accounted for 15.3% of kidney transplant candidates, and lower proportions of liver (5.1%), heart (5.3%) and lung (3.3%) candidates. Retransplants represented 12.4% of kidney, 9.0% of liver, 4.7% of heart and 5.3% of lung transplants performed in 2005. The absolute number of retransplants has grown most notably in kidney transplantation, increasing 40% over the last 10 years; the relative growth of retransplantation was most marked in heart and lung transplantation, increasing 66% and 217%, respectively. The growth of liver retransplantation was only 11%. Unadjusted graft survival remains significantly lower after retransplantation in the most recent cohorts analyzed. Even with careful case mix adjustments, the risk of graft failure following retransplantation is significantly higher than that observed for primary transplants.

Entities:  

Mesh:

Year:  2007        PMID: 17428290     DOI: 10.1111/j.1600-6143.2007.01786.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  46 in total

1.  Impact of MELD on waitlist outcome of retransplant candidates.

Authors:  H J Kim; J J Larson; Y S Lim; W R Kim; R A Pedersen; T M Therneau; C B Rosen
Journal:  Am J Transplant       Date:  2010-11-10       Impact factor: 8.086

2.  Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients.

Authors:  J R Cassuto; P P Reese; S Sonnad; R D Bloom; M H Levine; K M Olthoff; A Shaked; A Naji; P Abt
Journal:  Am J Transplant       Date:  2010-11       Impact factor: 8.086

3.  Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary.

Authors:  H Haddad; D Isaac; J F Legare; P Pflugfelder; P Hendry; M Chan; B Cantin; N Giannetti; S Zieroth; M White; W Warnica; K Doucette; V Rao; A Dipchand; M Cantarovich; W Kostuk; R Cecere; E Charbonneau; H Ross; N Poirier
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

4.  Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation.

Authors:  Marc Lúcia; Sergi Luque; Elena Crespo; Edoardo Melilli; Josep M Cruzado; Jaume Martorell; Marta Jarque; Salvador Gil-Vernet; Anna Manonelles; Josep M Grinyó; Oriol Bestard
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

Review 5.  Monitoring alloimmune response in kidney transplantation.

Authors:  Oriol Bestard; Paolo Cravedi
Journal:  J Nephrol       Date:  2016-05-31       Impact factor: 3.902

6.  Graft and patient survival outcomes of a third kidney transplant.

Authors:  Robert R Redfield; Meera Gupta; Eduardo Rodriguez; Alexander Wood; Peter L Abt; Matthew H Levine
Journal:  Transplantation       Date:  2015-02       Impact factor: 4.939

7.  Liver retransplantation in adults: a single-centre, 25-year experience.

Authors:  Ravi Marudanayagam; Vivekanandan Shanmugam; Bynvant Sandhu; Bridget K Gunson; Darius F Mirza; David Mayer; John Buckels; Simon R Bramhall
Journal:  HPB (Oxford)       Date:  2010-04       Impact factor: 3.647

8.  Being Thoughtful about Desensitization.

Authors:  Richard N Formica; Sanjay Kulkarni
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-03       Impact factor: 8.237

9.  Tissue engineering toward organ-specific regeneration and disease modeling.

Authors:  Christian Mandrycky; Kiet Phong; Ying Zheng
Journal:  MRS Commun       Date:  2017-07-31       Impact factor: 2.566

10.  Significant influence of the primary liver disease on the outcomes of hepatic retransplantation.

Authors:  A Qasim; B M Zaman; J Geoghegan; D Maguire; O Traynor; J Hegarty; P A McCormick
Journal:  Ir J Med Sci       Date:  2008-11-04       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.